Skip to main content
. 2020 Feb 3;10(6):2714–2726. doi: 10.7150/thno.40128

Figure 1.

Figure 1

Acute liver failure occurrence reduced intestinal and hepatic soyasaponin II levels in mice. C57BL/6J mice were intraperitoneally administrated with D-galactosamine (700 mg/kg) in combination with lipopolysaccharide (10 μg/kg). Cecal contents and liver were collected after LPS/GalN treatment for 6 h. (A) Soyasaponin II level in cecal content and the representative chromatogram (n=5). (B) Soyasaponin II levels in liver and the representative chromatogram (n=3 for LPS/GalN-treated and n=4 for PBS-treated mice). *p<0.05.